CF and non-CF bronchiectasis

CF and non-CF bronchiectasis

Efficacy and safety of TOBI Podhaler in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study
Michael R. Loebinger, Eva Polverino, James D. Chalmers, Harm A.W.M. Tiddens, Herman Goossens, Michael Tunney, Felix C. Ringshausen, Adam T. Hill, Rashidkhan Pathan, Gerhild Angyalosi, Francesco Blasi, Stuart J. Elborn, Charles S. Haworth

European Respiratory Journal Jan 2021, 57 (1) 2001451; DOI: 10.1183/13993003.01451-2020
Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis
Anabela S. Ramalho, Eva Fürstová, Annelotte M. Vonk, Marc Ferrante, Catherine Verfaillie, Lieven Dupont, Mieke Boon, Marijke Proesmans, Jeffrey M. Beekman, Ifat Sarouk, Carlos Vazquez Cordero, Francois Vermeulen, Kris De Boeck

European Respiratory Journal Jan 2021, 57 (1) 1902426; DOI: 10.1183/13993003.02426-2019
The assessment of short- and long-term changes in lung function in cystic fibrosis using ¹²⁹Xe MRI
Laurie J. Smith, Alex Horsley, Jody Bray, Paul J.C. Hughes, Alberto Biancardi, Graham Norquay, Martin Wildman, Noreen West, Helen Marshall, Jim M. Wild

European Respiratory Journal Dec 2020, 56 (6) 2000441; DOI: 10.1183/13993003.00441-2020
Changes in respiratory symptoms during 48-week treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies
James D. Chalmers, David Cipolla, Bruce Thompson, Angela M. Davis, Anne O'Donnell, Gregory Tino, Igor Gonda, Charles Haworth, Juergen Froehlich

European Respiratory Journal Oct 2020, 56 (4) 2000110; DOI: 10.1183/13993003.00110-2020
Sputum neutrophil elastase associates with microbiota and Pseudomonas aeruginosa in bronchiectasis
Martina Oriano, Andrea Gramegna, Leonardo Terranova, Giovanni Sotgiu, Imran Sulaiman, Luca Ruggiero, Laura Saderi, Benjamin Wu, James D. Chalmers, Leopoldo N. Segal, Paola Marchisio, Francesco Blasi, Stefano Aliberti

European Respiratory Journal Oct 2020, 56 (4) 2000769; DOI: 10.1183/13993003.00769-2020
Morbidity and mortality in carriers of the cystic fibrosis mutation CFTR Phe508del in the general population
Yunus Çolak, Børge G. Nordestgaard, Shoaib Afzal

European Respiratory Journal Sep 2020, 56 (3) 2000558; DOI: 10.1183/13993003.00558-2020
Inhaled aztreonam improves symptoms of cough and sputum production in patients with bronchiectasis: a post hoc analysis of the AIR-BX studies
Megan L. Crichton, Mike Lonergan, Alan F. Barker, Oriol Sibila, Pieter Goeminne, Amelia Shoemark, James D. Chalmers

European Respiratory Journal Jul 2020, 56 (1) 2000608; DOI: 10.1183/13993003.00608-2020
Association between physical activity and risk of hospitalisation in bronchiectasis
Victoria Alcaraz-Serrano, Elena Gimeno-Santos, Giulia Scioscia, Albert Gabarrús, Adria Navarro, Beatriz Herrero-Cortina, Rosanel Amaro, Laia Fernández-Barat, Antoni Torres

European Respiratory Journal Jun 2020, 55 (6) 1902138; DOI: 10.1183/13993003.02138-2019
Structural determinants of long-term functional outcomes in young children with cystic fibrosis
Lidija Turkovic, Daan Caudri, Tim Rosenow, Oded Breuer, Conor Murray, Harm A.W.M. Tiddens, Fiona Ramanauskas, Sarath C. Ranganathan, Graham L. Hall, Stephen M. Stick

European Respiratory Journal May 2020, 55 (5) 1900748; DOI: 10.1183/13993003.00748-2019
Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort
Naomi E. Wijker, Suzanna Vidmar, Keith Grimwood, Peter D. Sly, Catherine A. Byrnes, John B. Carlin, Peter J. Cooper, Colin F. Robertson, R. John Massie, Mariette P.C. Kemner van de Corput, Joyce Cheney, Harm A.W.M. Tiddens, Claire E. Wainwright

European Respiratory Journal Apr 2020, 55 (4) 1901694; DOI: 10.1183/13993003.01694-2019

Main menu

User menu

Search

CF and non-CF bronchiectasis

Pages

Contact us